Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Kintara Therapeutics Inc. buy melinda

Start price
€0.99
13.10.21 / 50%
Target price
€1.50
13.10.22
Performance (%)
-24.16%
Price
€0.75
22:26
Summary
This prediction is currently active. The price of Kintara Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -24.16%. This prediction currently runs until 13.10.22. The prediction end date can be changed by melinda at any time. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w
Kintara Therapeutics Inc. -24.16%
iShares Core DAX® 1.657%
iShares Core MSCI World 0.769%
iShares Nasdaq 100 0.811%
iShares S&P 500 0.599%

According to melinda what are the pros and cons of Kintara Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Delmar Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -24.16%
Target price 1.500
Change
Ends at

Buy mit Kursziel 1,5

Stopped prediction by melinda for Kintara Therapeutics Inc.

buy
Kintara Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.21
29.09.20
€1.80
04.11.21
-18.78%
11:29

Could be worthwhile Investment >10% per year